These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 20458439

  • 21. Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
    Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.
    J Thromb Haemost; 2010 Jan; 8(1):37-42. PubMed ID: 19818001
    [Abstract] [Full Text] [Related]

  • 22. Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting.
    Cuisset T, Frere C, Poyet R, Quilici J, Gaborit B, Bali L, Brissy O, Lambert M, Morange PE, Alessi MC, Bonnet JL.
    Arch Cardiovasc Dis; 2010 Jan; 103(1):39-45. PubMed ID: 20142119
    [Abstract] [Full Text] [Related]

  • 23. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
    Stellbaum C, Ayral Y, Morguet A, Schultheiss HP, Rauch U.
    Cardiovasc Revasc Med; 2012 Jan; 13(3):159-66. PubMed ID: 22503564
    [Abstract] [Full Text] [Related]

  • 24. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P, Eshtehardi P, Abrecht L, Zwahlen M, Schmidlin K, Windecker S, Meier B, Haeberli A, Hess OM.
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [Abstract] [Full Text] [Related]

  • 25. Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin.
    Zhang HZ, Yu LH, Kim MH.
    Platelets; 2013 Sep; 24(5):339-47. PubMed ID: 22774770
    [Abstract] [Full Text] [Related]

  • 26. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation.
    Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.
    Platelets; 2011 Sep; 22(3):188-95. PubMed ID: 21231857
    [Abstract] [Full Text] [Related]

  • 27. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H, Lask S, Engelhardt A, Mügge A.
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [Abstract] [Full Text] [Related]

  • 28. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG.
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [Abstract] [Full Text] [Related]

  • 29. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F, Barbato E, Patti G, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [Abstract] [Full Text] [Related]

  • 30. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ, Bernardo E, Palazuelos J, Desai B, Weisberg I, Alfonso F, Guzman LA, Hernández-Antolin R, Zenni MZ, Macaya C, Fernandez-Ortiz A, Bass TA.
    Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).
    Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G.
    Am J Cardiol; 2011 Apr 01; 107(7):995-1000. PubMed ID: 21256470
    [Abstract] [Full Text] [Related]

  • 33. Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention.
    Gaglia MA, Torguson R, Pakala R, Xue Z, Sardi G, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.
    J Interv Cardiol; 2011 Dec 01; 24(6):529-34. PubMed ID: 21919956
    [Abstract] [Full Text] [Related]

  • 34. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K, EPA (European Platelet Academy).
    JACC Cardiovasc Interv; 2013 Nov 01; 6(11):1111-28. PubMed ID: 24262612
    [Abstract] [Full Text] [Related]

  • 35. High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention.
    Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Harmsze AM, Hackeng CM, ten Berg JM.
    Heart; 2011 Jun 01; 97(12):983-90. PubMed ID: 21478385
    [Abstract] [Full Text] [Related]

  • 36. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.
    J Cardiovasc Pharmacol; 2010 Nov 01; 56(5):532-9. PubMed ID: 20729752
    [Abstract] [Full Text] [Related]

  • 37. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA, Working Group on On-Treatment Platelet Reactivity.
    J Am Coll Cardiol; 2013 Dec 17; 62(24):2261-73. PubMed ID: 24076493
    [Abstract] [Full Text] [Related]

  • 38. Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
    Gremmel T, Koppensteiner R, Panzer S.
    PLoS One; 2015 Dec 17; 10(6):e0129666. PubMed ID: 26058047
    [Abstract] [Full Text] [Related]

  • 39. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
    Würtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO, Hvas AM, Kristensen SD.
    JACC Cardiovasc Interv; 2010 Aug 17; 3(8):828-35. PubMed ID: 20723855
    [Abstract] [Full Text] [Related]

  • 40. Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
    Bernlochner I, Steinhubl S, Braun S, Morath T, Jaitner J, Stegherr J, Mehilli J, von Beckerath N, Schömig A, Kastrati A, Sibbing D.
    Thromb Haemost; 2010 Dec 17; 104(6):1193-200. PubMed ID: 20838744
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.